1. Progress in Development of Targeted Therapeutic Drugs for Acute Myeloid Leukemia
- Author
-
JI Xiaojun, ZHAO Tingli, MIAO Lei, SI Yaxuan, WU Jian, and XU Dan
- Subjects
aml ,targeted therapy ,immunotherapy ,drug progress ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Targeted therapeutic drugs for acute myeloid leukemia (AML) are showing immense development, thereby laying a solid foundation for the precise treatment of AML patients. The paper reviews four types of targeted drugs that have progressed rapidly for AML treatment (by targeting genes or signaling-pathway alterations, targeting apoptosis-related pathways, targeting cell-surface antigens, and targeting immune-related substances). We look forward to the future development directions of targeted drugs, providing references for hematologists and developers of new drugs for AML.
- Published
- 2023
- Full Text
- View/download PDF